DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Keppra XR (Levetiracetam) - Published Studies

 
 



Keppra XR Related Published Studies

Well-designed clinical trials related to Keppra XR (Levetiracetam)

Levetiracetam in the treatment of alcohol dependence: toward the end of the story? [2012]

A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients. [2012]

Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs. [2012]

A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease. [2011.07]

The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial. [2011.07]

Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial. [2011.06]

Evaluation of the subjective and reinforcing effects of diphenhydramine, levetiracetam, and valproic acid. [2011.06]

The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy. [2011.05]

A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target. [2011.05]

A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. [2011.04]

Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]). [2011.04]

Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease. [2011.02.01]

Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam. [2011.02]

Spotlight on levetiracetam in epilepsy. [2011]

Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease. [2011]

A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. [2011]

Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial. [2010.12]

Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial. [2010.11]

Intramuscular and intravenous levetiracetam in humans: safety and pharmacokinetics. [2010.10]

Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers. [2010.09]

An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia. [2010.09]

Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial. [2010.08.29]

Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial. [2010.07]

Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. [2010.05]

Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease. [2010.04]

Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. [2010.04]

Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial. [2010]

Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease. [2010]

Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. [2010]

Levetiracetam in spinal cord injury pain: a randomized controlled trial. [2009.12]

Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. [2009.11]

Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques. [2009.10]

Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: A randomized, double-blind, placebo-controlled, noninferiority trial. [2009.08.21]

Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies. [2009.07]

Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. [2009.07]

Levetiracetam in spinal cord injury pain: a randomized controlled trial. [2009.06.09]

Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. [2009.06]

Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. [2009.06]

A prospective pilot study of levetiracetam for body dysmorphic disorder. [2009.05]

Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. [2009.05]

Pharmacokinetics of levetiracetam XR 500mg tablets. [2009.04]

Effectiveness of levetiracetam in the treatment of lumbar radiculopathy: an open-label prospective cohort study. [2009.04]

Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial. [2009.03]

Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study. [2009.03]

The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis. [2009.03]

Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. [2009.03]

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures. [2009.03]

Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures. [2009]

Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures. [2009]

Bioequivalence of two formulations of levetiracetam. [2008.11]

Levetiracetam in absence epilepsy. [2008.11]

Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. [2008.09.12]

Effect of levetiracetam on the postmastectomy pain syndrome. [2008.08]

Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study. [2008.06]

Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study. [2008.04]

Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. [2008.02.19]

Effect of levetiracetam on cardiac repolarization in healthy subjects: A single-dose, randomized, placebo- and active-controlled, four-way crossover study. [2008.02]

Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial. [2008.02]

Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures. [2008.02]

The effects of levetiracetam on alcohol consumption in alcohol-dependent subjects: an open label study. [2008]

Levetiracetam and bleeding disorders. [2007.12]

Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. [2007.11.27]

Levetiracetam is not effective for essential tremor. [2007.11]

Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. [2007.11]

Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. [2007.10.30]

Impact of levetiracetam on mood and cognition during prednisone therapy. [2007.10]

Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine. [2007.10]

A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. [2007.09.15]

Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): An open-label, parallel group trial. [2007.06]

Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects. [2007.05]

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. [2007.02.06]

Well-designed clinical trials possibly related to Keppra XR (Levetiracetam)

Antiepileptic drugs and Tourette syndrome. [2013]

The established status epilepticus trial 2013. [2013]

Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization : a NICE single technology appraisal. [2013]

Pharmacotherapy to control behavioral symptoms in children with autism. [2012]

Established status epilepticus treatment trial (ESETT). [2011.10]

A prehospital randomized trial in convulsive status epilepticus. [2011.10]

Canine status epilepticus: a translational platform for human therapeutic trials. [2011.10]

Early treatment after stroke for the prevention of late epileptic seizures: a report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis. [2011.05]

Established status epilepticus treatment trial (ESETT). [2011]

Canine status epilepticus: a translational platform for human therapeutic trials. [2011]

Pharmacotherapeutics of Tourette syndrome and stereotypies in autism. [2010.12]

Should phenytoin or barbiturates be used as second-line anticonvulsant therapy for toxicological seizures? [2010.10]

Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. [2010.10]

Effects of antiepileptic drugs on associative LTP-like plasticity in human motor cortex. [2010.10]

Effects of antiepileptic drugs on associative LTP-like plasticity in human motor cortex. [2010]

Anticonvulsant drugs for pediatric migraine prevention: an evidence-based review. [2009.10]

A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. [2007.10]

Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. [2007.07]

The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. [2007.06]

The anaesthetic and intensive care of status epilepticus. [2007.04]

Other research related to Keppra XR (Levetiracetam)

Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types. [2014]

Ineffectiveness of topiramate and levetiracetam in infantile spasms non-responsive to steroids. Open labeled randomized prospective study. [2013]

The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients. [2013]

A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis. [2013]

Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. [2013]

Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review. [2012]

Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital. [2012]

Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for seizure prevention. [2012]

Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. [2012]

A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease. [2011]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017